Pekin Hardy Strauss Inc. Buys 3,435 Shares of Electromed, Inc. (NYSE:ELMD)

Pekin Hardy Strauss Inc. raised its stake in Electromed, Inc. (NYSE:ELMD) by 9.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,185 shares of the company’s stock after purchasing an additional 3,435 shares during the period. Pekin Hardy Strauss Inc.’s holdings in Electromed were worth $820,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ELMD. Vanguard Group Inc. boosted its holdings in Electromed by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 367,114 shares of the company’s stock valued at $5,929,000 after purchasing an additional 5,886 shares during the period. Gabelli Funds LLC boosted its holdings in Electromed by 76.1% in the 1st quarter. Gabelli Funds LLC now owns 35,867 shares of the company’s stock valued at $579,000 after purchasing an additional 15,500 shares during the period. Morgan Dempsey Capital Management LLC bought a new stake in Electromed in the 2nd quarter valued at $108,000. Renaissance Technologies LLC lifted its holdings in shares of Electromed by 4.8% during the 2nd quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock worth $1,548,000 after acquiring an additional 4,736 shares during the period. Finally, Marshall Wace LLP bought a new position in shares of Electromed during the 2nd quarter worth about $256,000. 40.82% of the stock is owned by institutional investors.

Electromed Stock Performance

NYSE:ELMD opened at $29.79 on Monday. The company has a 50-day moving average of $23.23 and a 200-day moving average of $18.20. The company has a market capitalization of $252.02 million, a price-to-earnings ratio of 41.38 and a beta of 0.27. Electromed, Inc. has a 52 week low of $9.81 and a 52 week high of $30.00.

Electromed (NYSE:ELMD) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.13. The company had revenue of $14.67 million during the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.